Log in to save to my catalogue

Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through so...

Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through so...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_becfb928778f4455b47dda2d76d7e062

Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation

About this item

Full title

Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2024-08, Vol.14 (1), p.19341-15, Article 19341

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Peripheral neurotoxicity is a dose-limiting adverse reaction of primary frontline chemotherapeutic agents, including vincristine. Neuropathy can be so disabling that patients drop out of potentially curative therapy, negatively impacting cancer prognosis. The hallmark of vincristine neurotoxicity is axonopathy, yet its underpinning mechanisms remai...

Alternative Titles

Full title

Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_becfb928778f4455b47dda2d76d7e062

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_becfb928778f4455b47dda2d76d7e062

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-024-70294-w

How to access this item